Endocrine surgeon Rashmi Roy, MD, FACS, discusses the diagnosis and management of primary hyperparathyroidism.
In a meta-analysis of 19 studies, investigators compared the effects of metabolic surgery vs medical therapy on mortality and the incidence of microvascular complications in type 2 diabetes. The findings were presented at ObesityWeek 2018.
Camillo Ricordi, MD, discusses different versions of a a bioengineered “mini organ” for islet transplantation that that mimics the native pancreas and could eliminate the need for insulin therapy for type 1 diabetes patients.
Marylyn Ritchie, PhD, Senior Investigator and Founding Director of the Biomedical and Translational Informatics Program, discusses whether genetic factors affect responses to medication and diet changes, and whether type 2 diabetes needs a reorganization into different therapeutic categories.